| Peter Thomas Evangelista, MD | |
|
125 Metro Center Blvd Ste 2000, Warwick, RI 02886-1785 | |
| (401) 432-2520 | |
| (401) 453-8220 |
| Full Name | Peter Thomas Evangelista |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 26 Years |
| Location | 125 Metro Center Blvd Ste 2000, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508854472 | NPI | - | NPPES |
| 003124047 | Other | CT MED ASSISTANCE | |
| 2465834 | Other | CIGNA | |
| 9356928 | Other | PHHCS | |
| 2081920 | Other | MASSMEDICAID | |
| 3707988 | Other | AETNA | |
| AA16956 | Other | RIHPILGRIM | |
| P00120864 | Other | RAILROAD MEDICARE | |
| 411628 | Other | BLUECHIP | |
| 9003434 | Other | RIMEDICALASSISTANCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD11408 (Rhode Island) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 217024 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South County Hospital Inc | Wakefield, RI | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Landmark Medical Center | Woonsocket, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rhode Island Medical Imaging | 8022097815 | 108 |
| Rhode Island Medical Imaging | 8022097815 | 108 |
News Archive
A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures.
The quality of the medical care for geriatric patients is a major investment for society and must imperatively be a research priority in Europe. This is why 50 European researchers, met on May 17 - 19 in Brussels, to define the research priorities in the field of biogerontology for the next 10 to 15 years.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma.
› Verified 1 days ago
| Entity Name | Rhode Island Medical Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205874930 PECOS PAC ID: 8022097815 Enrollment ID: O20040715000832 |
News Archive
A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures.
The quality of the medical care for geriatric patients is a major investment for society and must imperatively be a research priority in Europe. This is why 50 European researchers, met on May 17 - 19 in Brussels, to define the research priorities in the field of biogerontology for the next 10 to 15 years.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Thomas Evangelista, MD 125 Metro Center Blvd Ste 2000, Warwick, RI 02886-1785 Ph: (401) 432-2520 | Peter Thomas Evangelista, MD 125 Metro Center Blvd Ste 2000, Warwick, RI 02886-1785 Ph: (401) 432-2520 |
News Archive
A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures.
The quality of the medical care for geriatric patients is a major investment for society and must imperatively be a research priority in Europe. This is why 50 European researchers, met on May 17 - 19 in Brussels, to define the research priorities in the field of biogerontology for the next 10 to 15 years.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma.
› Verified 1 days ago
Marcelle L Piccolello, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2520 Fax: 401-453-8220 | |
David W Rowe, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 | |
Dr. Anthony G Bruzzese, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 Toll Gate Rd, Ste 101a, Warwick, RI 02886 Phone: 401-738-3100 Fax: 401-738-8505 | |
Dr. Robert C Ward, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2500 Fax: 401-453-8220 | |
Jeffrey D Potter, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 31 Bay Lawn Ave, Warwick, RI 02888 Phone: 401-941-6162 | |
Gaurav Jindal, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2500 Fax: 401-921-9212 | |
Hanan Ibrahim Khalil, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2520 Fax: 401-453-8220 |